.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

NARCAN Drug Profile

« Back to Dashboard
Narcan is a drug marketed by Bristol Myers Squibb, Adapt Pharma, and Adapt. and is included in five NDAs. It is available from three suppliers. There are two patents protecting this drug and one Paragraph IV challenge.

This drug has four patent family members in four countries.

The generic ingredient in NARCAN is naloxone hydrochloride. There are twelve drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the naloxone hydrochloride profile page.

Summary for Tradename: NARCAN

Patents:2
Applicants:3
NDAs:5
Suppliers / Packagers: see list3
Drug Prices: :see details

Pharmacology for Tradename: NARCAN

Drug ClassOpioid Antagonist
Mechanism of ActionOpioid Antagonists
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb
NARCAN
naloxone hydrochloride
INJECTABLE;INJECTION071311-001Jul 28, 1988DISCNNo► subscribe► subscribe
Bristol Myers Squibb
NARCAN
naloxone hydrochloride
INJECTABLE;INJECTION071083-001Jul 28, 1988DISCNNo► subscribe► subscribe
Adapt
NARCAN
naloxone hydrochloride
INJECTABLE;INJECTION016636-002Approved Prior to Jan 1, 1982DISCNNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: NARCAN

Drugname Dosage Strength RLD Submissiondate
naloxone hydrochlorideNasal Spray4 mg/sprayNarcan7/15/2016

International Patent Family for Tradename: NARCAN

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)2015136373► subscribe
Canada2942611► subscribe
Australia2015228541► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: NARCAN

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
292Luxembourg► subscribePRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc